ADIA

Adia Med, Inc. entered into a Membership Interest Purchase Agreement to sell seven units (7%…

The independent director control over proceeds and the consistent $50,000/unit valuation across two recent transactions suggest a deliberate capital raise structure. Monitor for further unit sales…

Adia Med, Inc. fully repaid and discharged a $1,000,000 unsecured revolving line of credit from…

The repayment of the CEO's credit facility removes a related-party debt but also eliminates a flexible funding source. Monitor upcoming quarterly filings for cash position and any new financing…

Adia Med, Inc. completed the sale of a 30% membership interest in its subsidiary Adia Labs LLC to…

Monitor Adia Med's use of the $1,000,000 cash proceeds — the prior cross-filing indicated the funds may support an uplisting to NASDAQ and bridge financing. The equal voting structure creates…

Adia Med, Inc. filed a declaratory judgment action in Florida state court seeking to quiet title…

Monitor the Florida court docket for responsive pleadings or a hearing date. A ruling quieting title in the company would be a significant positive catalyst, reducing share count by ~31% without any…